Number | Cited Articles |
1 |
Han-xiang Zhan, Bin Zhou, Yu-gang Cheng, Jian-wei Xu, Lei Wang, Guang-yong Zhang, San-yuan Hu. Crosstalk between stromal cells and cancer cells in pancreatic cancer: New insights into stromal biology. Cancer Letters 2017; 392: 83 doi: 10.1016/j.canlet.2017.01.041
|
2 |
Qiaofei Liu, Quan Liao, Yupei Zhao. Chemotherapy and tumor microenvironment of pancreatic cancer. Cancer Cell International 2017; 17(1) doi: 10.1186/s12935-017-0437-3
|
3 |
Enrico Spugnini, Mariantonia Logozzi, Rossella Di Raimo, Davide Mizzoni, Stefano Fais. A Role of Tumor-Released Exosomes in Paracrine Dissemination and Metastasis. International Journal of Molecular Sciences 2018; 19(12): 3968 doi: 10.3390/ijms19123968
|
4 |
Tianqi Su, Bo Yang, Tianren Gao, Tongjun Liu, Jiannan Li. Polymer nanoparticle-assisted chemotherapy of pancreatic cancer. Therapeutic Advances in Medical Oncology 2020; 12: 175883592091597 doi: 10.1177/1758835920915978
|
5 |
Ashenafi Bulle, Kian-Huat Lim. Beyond just a tight fortress: contribution of stroma to epithelial-mesenchymal transition in pancreatic cancer. Signal Transduction and Targeted Therapy 2020; 5(1) doi: 10.1038/s41392-020-00341-1
|
6 |
Yufu Wang, Tianyi Fang, Lining Huang, Hao Wang, Lei Zhang, Zhidong Wang, Yunfu Cui. Neutrophils infiltrating pancreatic ductal adenocarcinoma indicate higher malignancy and worse prognosis. Biochemical and Biophysical Research Communications 2018; 501(1): 313 doi: 10.1016/j.bbrc.2018.05.024
|
7 |
Ryo Koba, Hayato Fujita, Maiko Nishibori, Kiyoshi Saeki, Kinuko Nagayoshi, Yoshihiko Sadakari, Shuntaro Nagai, Oki Sekizawa, Kiyofumi Nitta, Tatsuya Manabe, Takashi Ueki, Tatsuhiro Ishida, Yoshinao Oda, Masafumi Nakamura.
Quantitative evaluation of the intratumoral distribution of platinum in oxaliplatin‐treated rectal cancer:
In situ
visualization of platinum
via
synchrotron radiation X‐ray fluorescence spectrometry
. International Journal of Cancer 2020; 146(9): 2498 doi: 10.1002/ijc.32592
|
8 |
Yiqiu Li, Fangfang Chen, Jun Chen, Siocheong Chan, Yi He, Wanli Liu, Ge Zhang. Disulfiram/Copper Induces Antitumor Activity against Both Nasopharyngeal Cancer Cells and Cancer-Associated Fibroblasts through ROS/MAPK and Ferroptosis Pathways. Cancers 2020; 12(1): 138 doi: 10.3390/cancers12010138
|
9 |
Jin Hong Lim, Joon Seong Park, Dong Sup Yoon. Preoperative fecal elastase-1 is a useful prognostic marker following curative resection of pancreatic cancer. HPB 2017; 19(5): 388 doi: 10.1016/j.hpb.2016.12.007
|
10 |
Letizia Porcelli, Rosa Iacobazzi, Roberta Di Fonte, Simona Serratì, Angelica Intini, Antonio Solimando, Oronzo Brunetti, Angela Calabrese, Francesco Leonetti, Amalia Azzariti, Nicola Silvestris. CAFs and TGF-β Signaling Activation by Mast Cells Contribute to Resistance to Gemcitabine/Nabpaclitaxel in Pancreatic Cancer. Cancers 2019; 11(3): 330 doi: 10.3390/cancers11030330
|
11 |
Myrna Hurtado, Sunil Shah, Maya Nair, Riyaz Basha. Breaking Tolerance to Pancreatic Cancer Unresponsiveness to Chemotherapy. 2019; : 13 doi: 10.1016/B978-0-12-817661-0.00002-0
|
12 |
Ishan Roy, Kathleen A Boyle, Emily P Vonderhaar, Noah P Zimmerman, Egal Gorse, A Craig Mackinnon, Rosa F Hwang, Janusz Franco-Barraza, Edna Cukierman, Susan Tsai, Douglas B Evans, Michael B Dwinell. Cancer cell chemokines direct chemotaxis of activated stellate cells in pancreatic ductal adenocarcinoma. Laboratory Investigation 2017; 97(3): 302 doi: 10.1038/labinvest.2016.146
|
13 |
Syue-Ting Chen, Ting-Chun Kuo, Ying-Yu Liao, Mei-Chun Lin, Yu-Wen Tien, Min-Chuan Huang. Silencing of MUC20 suppresses the malignant character of pancreatic ductal adenocarcinoma cells through inhibition of the HGF/MET pathway. Oncogene 2018; 37(46): 6041 doi: 10.1038/s41388-018-0403-0
|
14 |
Masanori Takehara, Yasushi Sato, Tetsuo Kimura, Kazuyoshi Noda, Hiroshi Miyamoto, Yasuteru Fujino, Jinsei Miyoshi, Fumika Nakamura, Hironori Wada, Yoshimi Bando, Tetsuya Ikemoto, Mitsuo Shimada, Naoki Muguruma, Tetsuji Takayama. Cancer‐associated adipocytes promote pancreatic cancer progression through SAA1 expression. Cancer Science 2020; 111(8): 2883 doi: 10.1111/cas.14527
|
15 |
Raffaella Belvedere, Valentina Bizzarro, Giovanni Forte, Fabrizio Dal Piaz, Luca Parente, Antonello Petrella. Annexin A1 contributes to pancreatic cancer cell phenotype, behaviour and metastatic potential independently of Formyl Peptide Receptor pathway. Scientific Reports 2016; 6(1) doi: 10.1038/srep29660
|
16 |
Michael Orth, Philipp Metzger, Sabine Gerum, Julia Mayerle, Günter Schneider, Claus Belka, Maximilian Schnurr, Kirsten Lauber. Pancreatic ductal adenocarcinoma: biological hallmarks, current status, and future perspectives of combined modality treatment approaches. Radiation Oncology 2019; 14(1) doi: 10.1186/s13014-019-1345-6
|
17 |
Qianwen Yu, Yue Qiu, Jianping Li, Xian Tang, Xuhui Wang, Xingli Cun, Shanshan Xu, Yayuan Liu, Man Li, Zhirong Zhang, Qin He. Targeting cancer-associated fibroblasts by dual-responsive lipid-albumin nanoparticles to enhance drug perfusion for pancreatic tumor therapy. Journal of Controlled Release 2020; 321: 564 doi: 10.1016/j.jconrel.2020.02.040
|
18 |
Xiaoqin Ji, Xixu Zhu, Xueguan Lu. Effect of cancer-associated fibroblasts on radiosensitivity of cancer cells. Future Oncology 2017; 13(17): 1537 doi: 10.2217/fon-2017-0054
|
19 |
Hirobumi Fuchigami, Shino Manabe, Masahiro Yasunaga, Yasuhiro Matsumura. Chemotherapy payload of anti-insoluble fibrin antibody-drug conjugate is released specifically upon binding to fibrin. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-32601-0
|
20 |
Caroline Y. K. Fong, Emma Burke, David Cunningham, Naureen Starling. Up-to-Date Tailored Systemic Treatment in Pancreatic Ductal Adenocarcinoma. Gastroenterology Research and Practice 2019; 2019: 1 doi: 10.1155/2019/7135437
|
21 |
Nicola Gaianigo, Davide Melisi, Carmine Carbone. EMT and Treatment Resistance in Pancreatic Cancer. Cancers 2017; 9(12): 122 doi: 10.3390/cancers9090122
|
22 |
Zhenfei Wang, Daguang Ma, Changshan Wang, Zhe Zhu, Yongyan Yang, Fenfang Zeng, Jianlong Yuan, Xia Liu, Yue Gao, Yongxia Chen, Yongfeng Jia. Triptonide inhibits the pathological functions of gastric cancer-associated fibroblasts. Biomedicine & Pharmacotherapy 2017; 96: 757 doi: 10.1016/j.biopha.2017.10.046
|
23 |
Satya Das, Jordan Berlin, Dana Cardin. Harnessing the Immune System in Pancreatic Cancer. Current Treatment Options in Oncology 2018; 19(10) doi: 10.1007/s11864-018-0566-5
|
24 |
Xiaoxiao Chen, Qianwen Yu, Yinke Liu, Qinglin Sheng, Kairong Shi, Yang Wang, Man Li, Zhirong Zhang, Qin He. Synergistic cytotoxicity and co-autophagy inhibition in pancreatic tumor cells and cancer-associated fibroblasts by dual functional peptide-modified liposomes. Acta Biomaterialia 2019; 99: 339 doi: 10.1016/j.actbio.2019.09.003
|
25 |
Divya Thomas, Prakash Radhakrishnan. Tumor Microenvironment. Advances in Experimental Medicine and Biology 2020; 1234: 57 doi: 10.1007/978-3-030-37184-5_5
|
26 |
Aleksandra Adamska, Omar Elaskalani, Aikaterini Emmanouilidi, Minkyoung Kim, Norbaini Binti Abdol Razak, Pat Metharom, Marco Falasca. Molecular and cellular mechanisms of chemoresistance in pancreatic cancer. Advances in Biological Regulation 2018; 68: 77 doi: 10.1016/j.jbior.2017.11.007
|
27 |
Farid G Khalafalla, Mohammad W Khan. Inflammation and Epithelial-Mesenchymal Transition in Pancreatic Ductal Adenocarcinoma: Fighting Against Multiple Opponents. Cancer Growth and Metastasis 2017; 10: 117906441770928 doi: 10.1177/1179064417709287
|
28 |
Michael Friberg Bruun Nielsen, Michael Bau Mortensen, Sönke Detlefsen. Typing of pancreatic cancer-associated fibroblasts identifies different subpopulations. World Journal of Gastroenterology 2018; 24(41): 4663-4678 doi: 10.3748/wjg.v24.i41.4663
|
29 |
Carlo Fabbri, Giulia Gibiino, Adele Fornelli, Vincenzo Cennamo, Daniela Grifoni, Michela Visani, Giorgia Acquaviva, Matteo Fassan, Sirio Fiorino, Silvia Giovanelli, Marco Bassi, Stefania Ghersi, Giovanni Tallini, Elio Jovine, Antonio Gasbarrini, Dario Biase. Team work and cytopathology molecular diagnosis of solid pancreatic lesions. Digestive Endoscopy 2017; 29(6): 657 doi: 10.1111/den.12845
|
30 |
Michael Karl Melzer, Frank Arnold, Katja Stifter, Friedemann Zengerling, Ninel Azoitei, Thomas Seufferlein, Christian Bolenz, Alexander Kleger. An Immunological Glance on Pancreatic Ductal Adenocarcinoma. International Journal of Molecular Sciences 2020; 21(9): 3345 doi: 10.3390/ijms21093345
|
31 |
Julie Dardare, Andréa Witz, Jean-Louis Merlin, Pauline Gilson, Alexandre Harlé. SMAD4 and the TGFβ Pathway in Patients with Pancreatic Ductal Adenocarcinoma. International Journal of Molecular Sciences 2020; 21(10): 3534 doi: 10.3390/ijms21103534
|
32 |
Jérémy Nigri, Meritxell Gironella, Christian Bressy, Elena Vila-Navarro, Julie Roques, Sophie Lac, Caroline Bontemps, Coraline Kozaczyk, Jérôme Cros, Daniel Pietrasz, Raphaël Maréchal, Jean-Luc Van Laethem, Juan Iovanna, Jean-Baptiste Bachet, Emma Folch-Puy, Richard Tomasini. PAP/REG3A favors perineural invasion in pancreatic adenocarcinoma and serves as a prognostic marker. Cellular and Molecular Life Sciences 2017; 74(22): 4231 doi: 10.1007/s00018-017-2579-9
|
33 |
Rachel L. O. Olson, Judith V. Forner, Pilar Navarro, Martin E. Fernandez-Zapico, Ahmed M. Elamir. Pancreatic Cancer. 2018; : 1 doi: 10.1007/978-1-4939-6631-8_89-1
|
34 |
Takashi Okumura, Kenoki Ohuchida, Shin Kibe, Chika Iwamoto, Yohei Ando, Shin Takesue, Hiromichi Nakayama, Toshiya Abe, Sho Endo, Kazuhiro Koikawa, Masafumi Sada, Kohei Horioka, Naoki Mochidome, Makoto Arita, Taiki Moriyama, Kohei Nakata, Yoshihiro Miyasaka, Takao Ohtsuka, Kazuhiro Mizumoto, Yoshinao Oda, Makoto Hashizume, Masafumi Nakamura. Adipose tissue-derived stromal cells are sources of cancer-associated fibroblasts and enhance tumor progression by dense collagen matrix. International Journal of Cancer 2019; 144(6): 1401 doi: 10.1002/ijc.31775
|
35 |
Hiromichi Nakayama, Kenoki Ohuchida, Masaki Yoshida, Tetsuyuki Miyazaki, Shin Takesue, Toshiya Abe, Sho Endo, Kazuhiro Koikawa, Takashi Okumura, Taiki Moriyama, Kohei Nakata, Yoshihiro Miyasaka, Kengo Shirahane, Tatsuya Manabe, Takao Ohtsuka, Hiroki Toma, Yohei Tominaga, Eishi Nagai, Kazuhiro Mizumoto, Yoshinao Oda, Masafumi Nakamura. Degree of desmoplasia in metastatic lymph node lesions is associated with lesion size and poor prognosis in pancreatic cancer patients. Oncology Letters 2017; 14(3): 3141 doi: 10.3892/ol.2017.6549
|
36 |
Rachel L. O. Olson, Judith V. Forner, Pilar Navarro, Martin E. Fernandez-Zapico, Ahmed M. Elamir. Pancreatic Cancer. 2018; : 539 doi: 10.1007/978-1-4939-7193-0_89
|
37 |
Thilo Hackert, Laura Wüsten, Markus W. Büchler. Tumor Angiogenesis. 2017; : 1 doi: 10.1007/978-3-319-31215-6_18-1
|
38 |
Magdalena Swierczewska, Serguei Kozlov, Pavan P. Adiseshaiah. Oncogenomics. 2019; : 313 doi: 10.1016/B978-0-12-811785-9.00022-3
|
39 |
Dimakatso Alice Senthebane, Arielle Rowe, Nicholas Ekow Thomford, Hendrina Shipanga, Daniella Munro, Mohammad A. M. Al Mazeedi, Hashim A. M. Almazyadi, Karlien Kallmeyer, Collet Dandara, Michael S. Pepper, M. Iqbal Parker, Kevin Dzobo. The Role of Tumor Microenvironment in Chemoresistance: To Survive, Keep Your Enemies Closer. International Journal of Molecular Sciences 2017; 18(7): 1586 doi: 10.3390/ijms18071586
|
40 |
In Kuk Cho, Haeryoung Kim, Jong-chan Lee, Jongchan Lee, Jaihwan Kim, Soomin Ahn, Hyunjin Park, Jin-Hyeok Hwang. Higher Tumor Cellularity in Resected Pancreatic Ductal Adenocarcinoma Is a Negative Prognostic Indicator. Gut and Liver 2020; 14(4): 521 doi: 10.5009/gnl19180
|
41 |
Belinda Lee, Peter Gibbs. Inflammation, Biomarkers and Immuno-Oncology Pathways in Pancreatic Cancer. Journal of Personalized Medicine 2019; 9(2): 20 doi: 10.3390/jpm9020020
|
42 |
I. V. Alekseenko, T. V. Vinogradova, E. D. Sverdlov. Genetic Regulatory Mechanisms of Evolution and Embryogenesis in a Distorting Mirror of Carcinogenesis. Russian Journal of Genetics 2018; 54(2): 145 doi: 10.1134/S1022795418020023
|
43 |
Sho Endo, Kohei Nakata, Kenoki Ohuchida, Shin Takesue, Hiromichi Nakayama, Toshiya Abe, Kazuhiro Koikawa, Takashi Okumura, Masafumi Sada, Kohei Horioka, Biao Zheng, Yusuke Mizuuchi, Chika Iwamoto, Masaharu Murata, Taiki Moriyama, Yoshihiro Miyasaka, Takao Ohtsuka, Kazuhiro Mizumoto, Yoshinao Oda, Makoto Hashizume, Masafumi Nakamura. Autophagy Is Required for Activation of Pancreatic Stellate Cells, Associated With Pancreatic Cancer Progression and Promotes Growth of Pancreatic Tumors in Mice. Gastroenterology 2017; 152(6): 1492 doi: 10.1053/j.gastro.2017.01.010
|
44 |
Alex Ney, Ismahan Mahamed, Andres Garcia, Pal Selbo, Patricia Sancho, Alexander J. MacRobert, Stephen P. Pereira, Pilar Acedo, Tayyaba Hasan. Combination light-based therapies to treat pancreatic cancer: a proof of concept. 17th International Photodynamic Association World Congress 2019; : 124 doi: 10.1117/12.2525305
|
45 |
Iera Hernandez-Unzueta, Aitor Benedicto, Irene Romayor, Alba Herrero, Eduardo Sanz, Beatriz Arteta, Elvira Olaso, Joana Márquez. Ocoxin Oral Solution Exerts an Antitumoral Effect in Pancreatic Cancer and Reduces the Stromal-Mediated Chemoresistance. Pancreas 2019; 48(4): 555 doi: 10.1097/MPA.0000000000001277
|
46 |
Chung-Tzu Hsueh, Julie H Selim, James Y Tsai, Chung-Tsen Hsueh. Nanovectors for anti-cancer drug delivery in the treatment of advanced pancreatic adenocarcinoma. World Journal of Gastroenterology 2016; 22(31): 7080-7090 doi: 10.3748/wjg.v22.i31.7080
|
47 |
Fangkun Liu, Jing Huang, Bo Ning, Zhixiong Liu, Shen Chen, Wei Zhao. Drug Discovery via Human-Derived Stem Cell Organoids. Frontiers in Pharmacology 2016; 7 doi: 10.3389/fphar.2016.00334
|
48 |
Ran Xue, Lin Hua, Wenbin Xu, Yan Gao, Yanhua Pang, Jianyu Hao. Derivation and Validation of the Potential Core Genes in Pancreatic Cancer for Tumor-Stroma Crosstalk. BioMed Research International 2018; 2018: 1 doi: 10.1155/2018/4283673
|
49 |
David L Marks, Rachel LO Olson, Martin E Fernandez-Zapico. Epigenetic control of the tumor microenvironment. Epigenomics 2016; 8(12): 1671 doi: 10.2217/epi-2016-0110
|
50 |
Thilo Hackert, Laura Wüsten, Markus W. Büchler. Tumor Angiogenesis. 2019; : 415 doi: 10.1007/978-3-319-33673-2_18
|
51 |
Toshio Takahashi. Organoids for Drug Discovery and Personalized Medicine. Annual Review of Pharmacology and Toxicology 2019; 59(1): 447 doi: 10.1146/annurev-pharmtox-010818-021108
|
52 |
Alessandro Poggi, Serena Varesano, Maria Raffaella Zocchi. How to Hit Mesenchymal Stromal Cells and Make the Tumor Microenvironment Immunostimulant Rather Than Immunosuppressive. Frontiers in Immunology 2018; 9 doi: 10.3389/fimmu.2018.00262
|
53 |
Kivanc Görgülü, Kalliope N. Diakopoulos, Jiaoyu Ai, Benjamin Schoeps, Derya Kabacaoglu, Angeliki-Faidra Karpathaki, Katrin J. Ciecielski, Ezgi Kaya-Aksoy, Dietrich A. Ruess, Alexandra Berninger, Marlena Kowalska, Marija Stevanovic, Sonja M. Wörmann, Thomas Wartmann, Yue Zhao, Walter Halangk, Svetlana Voronina, Alexey Tepikin, Anna Melissa Schlitter, Katja Steiger, Anna Artati, Jerzy Adamski, Michaela Aichler, Axel Walch, Martin Jastroch, Götz Hartleben, Christos S. Mantzoros, Wilko Weichert, Roland M. Schmid, Stephan Herzig, Achim Krüger, Bruno Sainz, Marina Lesina, Hana Algül. Levels of the Autophagy-Related 5 Protein Affect Progression and Metastasis of Pancreatic Tumors in Mice. Gastroenterology 2019; 156(1): 203 doi: 10.1053/j.gastro.2018.09.053
|
54 |
Gemma van Duijneveldt, Michael D.W. Griffin, Tracy L. Putoczki. Emerging roles for the IL-6 family of cytokines in pancreatic cancer. Clinical Science 2020; 134(16): 2091 doi: 10.1042/CS20191211
|
55 |
Wei Mu, Zhe Wang, Margot Zöller. Ping-Pong—Tumor and Host in Pancreatic Cancer Progression. Frontiers in Oncology 2019; 9 doi: 10.3389/fonc.2019.01359
|
56 |
Abigail Coetzee, Richard Grose, Hemant Kocher. . Current Topics in Microbiology and Immunology 2019; doi: 10.1007/82_2019_155
|
57 |
Micah N. Sagini, Michael Zepp, Frank Bergmann, Matthias Bozza, Richard Harbottle, Martin R. Berger. The expression of genes contributing to pancreatic adenocarcinoma progression is influenced by the respective environment. Genes & Cancer 2018; 9(3-4): 114 doi: 10.18632/genesandcancer.173
|
58 |
Ayuko Hoshino, Han Sang Kim, Linda Bojmar, Kofi Ennu Gyan, Michele Cioffi, Jonathan Hernandez, Constantinos P. Zambirinis, Gonçalo Rodrigues, Henrik Molina, Søren Heissel, Milica Tesic Mark, Loïc Steiner, Alberto Benito-Martin, Serena Lucotti, Angela Di Giannatale, Katharine Offer, Miho Nakajima, Caitlin Williams, Laura Nogués, Fanny A. Pelissier Vatter, Ayako Hashimoto, Alexander E. Davies, Daniela Freitas, Candia M. Kenific, Yonathan Ararso, Weston Buehring, Pernille Lauritzen, Yusuke Ogitani, Kei Sugiura, Naoko Takahashi, Maša Alečković, Kayleen A. Bailey, Joshua S. Jolissant, Huajuan Wang, Ashton Harris, L. Miles Schaeffer, Guillermo García-Santos, Zoe Posner, Vinod P. Balachandran, Yasmin Khakoo, G. Praveen Raju, Avigdor Scherz, Irit Sagi, Ruth Scherz-Shouval, Yosef Yarden, Moshe Oren, Mahathi Malladi, Mary Petriccione, Kevin C. De Braganca, Maria Donzelli, Cheryl Fischer, Stephanie Vitolano, Geraldine P. Wright, Lee Ganshaw, Mariel Marrano, Amina Ahmed, Joe DeStefano, Enrico Danzer, Michael H.A. Roehrl, Norman J. Lacayo, Theresa C. Vincent, Martin R. Weiser, Mary S. Brady, Paul A. Meyers, Leonard H. Wexler, Srikanth R. Ambati, Alexander J. Chou, Emily K. Slotkin, Shakeel Modak, Stephen S. Roberts, Ellen M. Basu, Daniel Diolaiti, Benjamin A. Krantz, Fatima Cardoso, Amber L. Simpson, Michael Berger, Charles M. Rudin, Diane M. Simeone, Maneesh Jain, Cyrus M. Ghajar, Surinder K. Batra, Ben Z. Stanger, Jack Bui, Kristy A. Brown, Vinagolu K. Rajasekhar, John H. Healey, Maria de Sousa, Kim Kramer, Sujit Sheth, Jeanine Baisch, Virginia Pascual, Todd E. Heaton, Michael P. La Quaglia, David J. Pisapia, Robert Schwartz, Haiying Zhang, Yuan Liu, Arti Shukla, Laurence Blavier, Yves A. DeClerck, Mark LaBarge, Mina J. Bissell, Thomas C. Caffrey, Paul M. Grandgenett, Michael A. Hollingsworth, Jacqueline Bromberg, Bruno Costa-Silva, Hector Peinado, Yibin Kang, Benjamin A. Garcia, Eileen M. O’Reilly, David Kelsen, Tanya M. Trippett, David R. Jones, Irina R. Matei, William R. Jarnagin, David Lyden. Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers. Cell 2020; 182(4): 1044 doi: 10.1016/j.cell.2020.07.009
|
59 |
Karolina Najder, Boris Musset, Otto Lindemann, Etmar Bulk, Albrecht Schwab, Benedikt Fels. The function of TRP channels in neutrophil granulocytes. Pflügers Archiv - European Journal of Physiology 2018; 470(7): 1017 doi: 10.1007/s00424-018-2146-8
|
60 |
Xiao Sun, Nengyi Ni, Yanling Ma, Yan Wang, David Tai Leong. Retooling Cancer Nanotherapeutics’ Entry into Tumors to Alleviate Tumoral Hypoxia. Small 2020; 16(41): 2003000 doi: 10.1002/smll.202003000
|
61 |
Amalia Azzariti, Rosa Maria Iacobazzi, Roberta Di Fonte, Letizia Porcelli, Roberto Gristina, Pietro Favia, Francesco Fracassi, Ilaria Trizio, Nicola Silvestris, Gabriella Guida, Stefania Tommasi, Eloisa Sardella. Plasma-activated medium triggers cell death and the presentation of immune activating danger signals in melanoma and pancreatic cancer cells. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-40637-z
|
62 |
V. Taucher, Johannes Haybaeck. Mechanisms of Molecular Carcinogenesis – Volume 2. 2017; : 83 doi: 10.1007/978-3-319-53661-3_5
|
63 |
Sven H. Loosen, Pia Hoening, Niklas Puethe, Mark Luedde, Martina Spehlmann, Tom F. Ulmer, David V. Cardenas, Sanchari Roy, Frank Tacke, Christian Trautwein, Ulf P. Neumann, Tom Luedde, Christoph Roderburg. Elevated serum levels of bone sialoprotein (BSP) predict long-term mortality in patients with pancreatic adenocarcinoma. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-018-38352-2
|
64 |
Mehmet Akce, Bassel F El-Rayes. Novel Strategies on the Horizon for Metastatic Pancreatic Cancer Management. Oncology & Hematology Review (US) 2019; 15(1): 27 doi: 10.17925/OHR.2019.15.1.27
|
65 |
Shona Hendry, Roberto Salgado, Thomas Gevaert, Prudence A. Russell, Tom John, Bibhusal Thapa, Michael Christie, Koen van de Vijver, M.V. Estrada, Paula I. Gonzalez-Ericsson, Melinda Sanders, Benjamin Solomon, Cinzia Solinas, Gert G.G.M. Van den Eynden, Yves Allory, Matthias Preusser, Johannes Hainfellner, Giancarlo Pruneri, Andrea Vingiani, Sandra Demaria, Fraser Symmans, Paolo Nuciforo, Laura Comerma, E.A. Thompson, Sunil Lakhani, Seong-Rim Kim, Stuart Schnitt, Cecile Colpaert, Christos Sotiriou, Stefan J. Scherer, Michail Ignatiadis, Sunil Badve, Robert H. Pierce, Giuseppe Viale, Nicolas Sirtaine, Frederique Penault-Llorca, Tomohagu Sugie, Susan Fineberg, Soonmyung Paik, Ashok Srinivasan, Andrea Richardson, Yihong Wang, Ewa Chmielik, Jane Brock, Douglas B. Johnson, Justin Balko, Stephan Wienert, Veerle Bossuyt, Stefan Michiels, Nils Ternes, Nicole Burchardi, Stephen J. Luen, Peter Savas, Frederick Klauschen, Peter H. Watson, Brad H. Nelson, Carmen Criscitiello, Sandra O’Toole, Denis Larsimont, Roland de Wind, Giuseppe Curigliano, Fabrice André, Magali Lacroix-Triki, Mark van de Vijver, Federico Rojo, Giuseppe Floris, Shahinaz Bedri, Joseph Sparano, David Rimm, Torsten Nielsen, Zuzana Kos, Stephen Hewitt, Baljit Singh, Gelareh Farshid, Sibylle Loibl, Kimberly H. Allison, Nadine Tung, Sylvia Adams, Karen Willard-Gallo, Hugo M. Horlings, Leena Gandhi, Andre Moreira, Fred Hirsch, Maria V. Dieci, Maria Urbanowicz, Iva Brcic, Konstanty Korski, Fabien Gaire, Hartmut Koeppen, Amy Lo, Jennifer Giltnane, Marlon C. Rebelatto, Keith E. Steele, Jiping Zha, Kenneth Emancipator, Jonathan W. Juco, Carsten Denkert, Jorge Reis-Filho, Sherene Loi, Stephen B. Fox. Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors. Advances In Anatomic Pathology 2017; 24(6): 311 doi: 10.1097/PAP.0000000000000161
|
66 |
Yaojie Fu, Shanshan Liu, Shan Zeng, Hong Shen. The critical roles of activated stellate cells-mediated paracrine signaling, metabolism and onco-immunology in pancreatic ductal adenocarcinoma. Molecular Cancer 2018; 17(1) doi: 10.1186/s12943-018-0815-z
|
67 |
Kai Wang, Graham S Baldwin, Mehrdad Nikfarjam, Hong He. p21-activated kinase signalling in pancreatic cancer: New insights into tumour biology and immune modulation. World Journal of Gastroenterology 2018; 24(33): 3709-3723 doi: 10.3748/wjg.v24.i33.3709
|
68 |
Stella Totti, Spyros I. Vernardis, Lisiane Meira, Pedro A. Pérez-Mancera, Eithne Costello, William Greenhalf, Daniel Palmer, John Neoptolemos, Athanasios Mantalaris, Eirini G. Velliou. Designing a bio-inspired biomimetic in vitro system for the optimization of ex vivo studies of pancreatic cancer. Drug Discovery Today 2017; 22(4): 690 doi: 10.1016/j.drudis.2017.01.012
|
69 |
Daniel Ansari, Maria Carvajo, Monika Bauden, Roland Andersson. Pancreatic cancer stroma: controversies and current insights. Scandinavian Journal of Gastroenterology 2017; 52(6-7): 641 doi: 10.1080/00365521.2017.1293726
|
70 |
Irina Negut, Valentina Grumezescu. Biomedical Applications of Nanoparticles. 2019; : 63 doi: 10.1016/B978-0-12-816506-5.00012-7
|
71 |
Hiromitsu Maehira, Toru Miyake, Hiroya Iida, Aya Tokuda, Haruki Mori, Daiki Yasukawa, Ken-ichi Mukaisho, Tomoharu Shimizu, Masaji Tani. Vimentin Expression in Tumor Microenvironment Predicts Survival in Pancreatic Ductal Adenocarcinoma: Heterogeneity in Fibroblast Population. Annals of Surgical Oncology 2019; 26(13): 4791 doi: 10.1245/s10434-019-07891-x
|
72 |
Yasuhiro Matsumura. Cancer Drug Delivery Systems Based on the Tumor Microenvironment. 2019; : 255 doi: 10.1007/978-4-431-56880-3_11
|
73 |
Patrizia Procacci, Claudia Moscheni, Patrizia Sartori, Michele Sommariva, Nicoletta Gagliano. Tumor–Stroma Cross-Talk in Human Pancreatic Ductal Adenocarcinoma: A Focus on the Effect of the Extracellular Matrix on Tumor Cell Phenotype and Invasive Potential. Cells 2018; 7(10): 158 doi: 10.3390/cells7100158
|
74 |
Emma Eriksson, Ioanna Milenova, Jessica Wenthe, Rafael Moreno, Ramon Alemany, Angelica Loskog. IL-6 Signaling Blockade during CD40-Mediated Immune Activation Favors Antitumor Factors by Reducing TGF-β, Collagen Type I, and PD-L1/PD-1. The Journal of Immunology 2019; 202(3): 787 doi: 10.4049/jimmunol.1800717
|
75 |
Emanuela Dell’Aquila, Claudia Angela Maria Fulgenzi, Alessandro Minelli, Fabrizio Citarella, Marco Stellato, Francesco Pantano, Marco Russano, Maria Concetta Cursano, Andrea Napolitano, Tea Zeppola, Bruno Vincenzi, Giuseppe Tonini, Daniele Santini. Prognostic and predictive factors in pancreatic cancer. Oncotarget 2020; 11(10): 924 doi: 10.18632/oncotarget.27518
|
76 |
Andrii Khomiak, Marius Brunner, Maximilian Kordes, Stina Lindblad, Rainer Christoph Miksch, Daniel Öhlund, Ivonne Regel. Recent Discoveries of Diagnostic, Prognostic and Predictive Biomarkers for Pancreatic Cancer. Cancers 2020; 12(11): 3234 doi: 10.3390/cancers12113234
|
77 |
Wen-Quan Wang, Liang Liu, Jin-Zhi Xu, Xian-Jun Yu. Reflections on depletion of tumor stroma in pancreatic cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2019; 1871(2): 267 doi: 10.1016/j.bbcan.2019.01.007
|
78 |
Eleonora Rofi, Caterina Vivaldi, Marzia Del Re, Elena Arrigoni, Stefania Crucitta, Niccola Funel, Stefano Fogli, Enrico Vasile, Gianna Musettini, Lorenzo Fornaro, Alfredo Falcone, Romano Danesi. The emerging role of liquid biopsy in diagnosis, prognosis and treatment monitoring of pancreatic cancer. Pharmacogenomics 2019; 20(1): 49 doi: 10.2217/pgs-2018-0149
|
79 |
Enrica Saponara, Michele Visentin, Francesco Baschieri, Gitta Seleznik, Paola Martinelli, Irene Esposito, Johanna Buschmann, Rong Chen, Rossella Parrotta, Nathalie Borgeaud, Marta Bombardo, Ermanno Malagola, Amedeo Caflisch, Hesso Farhan, Rolf Graf, Sabrina Sonda. Serotonin uptake is required for Rac1 activation in Kras-induced acinar-to-ductal metaplasia in the pancreas. The Journal of Pathology 2018; 246(3): 352 doi: 10.1002/path.5147
|
80 |
Rui Tang, Christopher W Murray, Ian L Linde, Nicholas J Kramer, Zhonglin Lyu, Min K Tsai, Leo C Chen, Hongchen Cai, Aaron D Gitler, Edgar Engleman, Wonjae Lee, Monte M Winslow. A versatile system to record cell-cell interactions. eLife 2020; 9 doi: 10.7554/eLife.61080
|
81 |
Afsane Bahrami, Majid Khazaei, Fariba Bagherieh, Majid Ghayour-Mobarhan, Mina Maftouh, Seyed Mahdi Hassanian, Amir Avan. Targeting stroma in pancreatic cancer: Promises and failures of targeted therapies. Journal of Cellular Physiology 2017; 232(11): 2931 doi: 10.1002/jcp.25798
|
82 |
Jennifer L. Miller-Ocuin, Xiaoyan Liang, Brian A. Boone, W. Reed Doerfler, Aatur D. Singhi, Daolin Tang, Rui Kang, Michael T. Lotze, Herbert J. Zeh. DNA released from neutrophil extracellular traps (NETs) activates pancreatic stellate cells and enhances pancreatic tumor growth. OncoImmunology 2019; 8(9): e1605822 doi: 10.1080/2162402X.2019.1605822
|
83 |
M Pergamo, G Miller. Myeloid-derived suppressor cells and their role in pancreatic cancer. Cancer Gene Therapy 2017; 24(3): 100 doi: 10.1038/cgt.2016.65
|
84 |
Mohammad Awaji, Rakesh Singh. Cancer-Associated Fibroblasts’ Functional Heterogeneity in Pancreatic Ductal Adenocarcinoma. Cancers 2019; 11(3): 290 doi: 10.3390/cancers11030290
|
85 |
Junpei Yamaguchi, Yukihiro Yokoyama, Toshio Kokuryo, Tomoki Ebata, Atsushi Enomoto, Masato Nagino. Trefoil factor 1 inhibits epithelial-mesenchymal transition of pancreatic intraepithelial neoplasm. Journal of Clinical Investigation 2018; 128(8): 3619 doi: 10.1172/JCI97755
|
86 |
Claudia Minici, Elena Rigamonti, Marco Lanzillotta, Antonella Monno, Lucrezia Rovati, Takashi Maehara, Naoki Kaneko, Vikram Deshpande, Maria Pia Protti, Lucia De Monte, Cristina Scielzo, Stefano Crippa, Paolo Giorgio Arcidiacono, Erica Dugnani, Lorenzo Piemonti, Massimo Falconi, Shiv Pillai, Angelo A. Manfredi, Emanuel Della-Torre. B lymphocytes contribute to stromal reaction in pancreatic ductal adenocarcinoma. OncoImmunology 2020; 9(1): 1794359 doi: 10.1080/2162402X.2020.1794359
|
87 |
Sascha Rahn, Philippe Dänzer Barbosa, Julia Luisa Möller, Nourhane Ammar, Tobias Demetrowitsch, Ole Helm, Daniela Wesch, Bence Sipos, Christoph Röcken, Karin Schwarz, Heiner Schäfer, Susanne Sebens. Inflammation Associated Pancreatic Tumorigenesis: Upregulation of Succinate Dehydrogenase (Subunit B) Reduces Cell Growth of Pancreatic Ductal Epithelial Cells. Cancers 2019; 12(1): 42 doi: 10.3390/cancers12010042
|
88 |
Marco Tomasetti, Wan Lee, Lory Santarelli, Jiri Neuzil. Exosome-derived microRNAs in cancer metabolism: possible implications in cancer diagnostics and therapy. Experimental & Molecular Medicine 2017; 49(1): e285 doi: 10.1038/emm.2016.153
|
89 |
Pedro M. Aponte, Andrés Caicedo. Stemness in Cancer: Stem Cells, Cancer Stem Cells, and Their Microenvironment. Stem Cells International 2017; 2017: 1 doi: 10.1155/2017/5619472
|
90 |
Marta Overchuk, Gang Zheng. Overcoming obstacles in the tumor microenvironment: Recent advancements in nanoparticle delivery for cancer theranostics. Biomaterials 2018; 156: 217 doi: 10.1016/j.biomaterials.2017.10.024
|
91 |
Michael Friberg Bruun Nielsen, Michael Bau Mortensen, Sönke Detlefsen. Identification of markers for quiescent pancreatic stellate cells in the normal human pancreas. Histochemistry and Cell Biology 2017; 148(4): 359 doi: 10.1007/s00418-017-1581-5
|
92 |
Fabio Grizzi, Sirio Fiorino, Dorina Qehajaj, Adele Fornelli, Carlo Russo, Dario de Biase, Michele Masetti, Laura Mastrangelo, Matteo Zanello, Raffaele Lombardi, Andrea Domanico, Esterita Accogli, Andrea Tura, Leonardo Mirandola, Maurizio Chiriva-Internati, Robert S. Bresalier, Elio Jovine, Paolo Leandri, Luca Di Tommaso. Computer-aided assessment of the extra-cellular matrix during pancreatic carcinogenesis: a pilot study. Journal of Translational Medicine 2019; 17(1) doi: 10.1186/s12967-019-1817-3
|
93 |
Manoj Amrutkar, Ivar Gladhaug. Pancreatic Cancer Chemoresistance to Gemcitabine. Cancers 2017; 9(12): 157 doi: 10.3390/cancers9110157
|
94 |
Bin Yan, Liang Cheng, Zhengdong Jiang, Ke Chen, Cancan Zhou, Liankang Sun, Junyu Cao, Weikun Qian, Jie Li, Tao Shan, Jianjun Lei, Qingyong Ma, Jiguang Ma. Resveratrol Inhibits ROS-Promoted Activation and Glycolysis of Pancreatic Stellate Cells via Suppression of miR-21. Oxidative Medicine and Cellular Longevity 2018; 2018: 1 doi: 10.1155/2018/1346958
|
95 |
Yosuke Mukai, Daisaku Yamada, Hidetoshi Eguchi, Yoshifumi Iwagami, Tadafumi Asaoka, Takehiro Noda, Koichi Kawamoto, Kunihito Gotoh, Shogo Kobayashi, Yutaka Takeda, Masahiro Tanemura, Masaki Mori, Yuichiro Doki. Vitamin D Supplementation is a Promising Therapy for Pancreatic Ductal Adenocarcinoma in Conjunction with Current Chemoradiation Therapy. Annals of Surgical Oncology 2018; 25(7): 1868 doi: 10.1245/s10434-018-6431-8
|
96 |
Richard L. Sleightholm, Beth K. Neilsen, Jing Li, Maria M. Steele, Rakesh K. Singh, Michael A. Hollingsworth, David Oupicky. Emerging roles of the CXCL12/CXCR4 axis in pancreatic cancer progression and therapy. Pharmacology & Therapeutics 2017; 179: 158 doi: 10.1016/j.pharmthera.2017.05.012
|
97 |
Kate Young, Daniel J. Hughes, David Cunningham, Naureen Starling. Immunotherapy and pancreatic cancer: unique challenges and potential opportunities. Therapeutic Advances in Medical Oncology 2018; 10: 175883591881628 doi: 10.1177/1758835918816281
|
98 |
Veronique Veenstra, Andrea Garcia-Garijo, Hanneke van Laarhoven, Maarten Bijlsma. Extracellular Influences: Molecular Subclasses and the Microenvironment in Pancreatic Cancer. Cancers 2018; 10(2): 34 doi: 10.3390/cancers10020034
|
99 |
Thomas M. Pausch, Elisa Aue, Naita M. Wirsik, Aida Freire Valls, Ying Shen, Praveen Radhakrishnan, Thilo Hackert, Martin Schneider, Thomas Schmidt. Metastasis-associated fibroblasts promote angiogenesis in metastasized pancreatic cancer via the CXCL8 and the CCL2 axes. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-62416-x
|
100 |
Vijay Sagar Madamsetty, Krishnendu Pal, Shamit Kumar Dutta, Enfeng Wang, Debabrata Mukhopadhyay. Targeted Dual Intervention-Oriented Drug-Encapsulated (DIODE) Nanoformulations for Improved Treatment of Pancreatic Cancer. Cancers 2020; 12(5): 1189 doi: 10.3390/cancers12051189
|